European Hematology Association abstracts 2024

Congratulations to Dr Luke Wang, Ms Eliza Chung and other LaRDR investigators for having the following abstracts accepted by the European Hematology Association (EHA) conference.

The Definition and Use of Bulk Disease in Phase 3 Lymphoma Trials: A Comprehensive Literature Review

• This is a literature review summarising the definitions, utility and prognostic implications of bulk tumours in four lymphoma subtypes from phase 3 randomised clinical trials.

Definition and Use of Bulky Disease in Lymphoma Care: A Study from the Australasian Lymphoma and Related Diseases Registry (LaRDR)

• This is an Australasian Lymphoma and Related Disease Registry study describing the characteristics of Australian and New Zealand patients with bulk tumours, their treatment patterns and outcomes in key lymphoma subtypes.